TheStreet's Jim Cramer says he's a big fan of holding cash right now and waiting for further declines before buying shares. 'I think that you want to wait. If China holds its 3,500 level. If not, you’ll see another sell-off and that will be your opportunity. I never like to commit cash all at once. If we’re down 2 1/2-percent from the highs, how about waiting down 5 to 7-percent.' @JoelTalks asks Cramer if he'd be a buyer of Apple (AAPL) and Netflix (NFLX) if he had a longer-term time horizon and Cramer said 'absolutely.' @TodMac asks if Cramer is a fan of Peabody Energy (BTU) considering that George Soros recently bought shares. Cramer said, 'I’m very anti-coal stocks. I think there are ways to invest in coal through the debt. I think buying Peabody is like buying a lottery ticket. And, I’ll go buy a lottery ticket if I want one.' @MarkBell00 asks if Valeant Pharmaceucticals (VRX) may have overpaid for Sprout Pharmaceuticals. 'I think Valeant is looking like SunEdison (SUNE). I think this was the deal that went too far. People have liked all the deals beforehand and they didn’t this time and I think that Valeant is a stock that I don’t want to own anymore.' Send your questions to @JimCramer, with #CramerQ.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.